2026 May 11th, 16th Annual Moffitt Scientific Symposium, Moffitt.

~Hannah will present a poster and a featured poster talk "Optimal regimens of adoptive cell therapy in a virtual murine cohort of bladder cancer." ~Ana will present a poster: "From the inside or the outside? A computational study of the mechanical interactions involved in DCIS microinvasions." ~Emilie will presente a poster: "Optimization of melanoma treatments in the hypoxic tumor microenvironment with CAR-T cells of different affinities." ~Kayode will present a poster "Optimizing schedules for combination of adoptive T cells, dendritic cell vaccines, and anti-PD-L1 treatments for melanoma using a reinforcement learning approach." ~Our clinical collaborator David Nusbaum will also present a talk "Feasibility and safety of intravesical therapy with autologous tumor infiltrating lymphocytes (TIL) in BCG-exposed non-muscle invasive bladder cancer."

 

2026 March 13th, an updated preprint from our lab: "PETIL: Predicting Expansion of Tumor Infiltrating Lymphocytes for the Adoptive Cell Immunotherapy in Bladder Cancers" by Kayode Olumoyin in collaboration with Shari Pilon-Thomas and Mike Poch labs and Kasia Rejniak, has been published in BioRxiv, link to the article

 

2026 March 13th, a new paper from our collaboration with Shari Pilon-Thomas lab: "Transdermal bicarbonate buffer therapy increases intratumoral pH and elicits antitumor responses in bladder cancer" has been published in Frontiers in Immunology, link to the article

 

2026 March 10th, a new preprint from our lab: "A virtual cohort framework with applications to adoptive cell therapy in bladder cancer" by Hannah Anderson in collaboration with Shari Pilon-Thomas and Mike Poch labs and Kasia Rejniak, has been published in BioRxiv, link to the article

 

2026 March 6th, Ms. Emilie Favier, a graduate student in our lab, has passes her qualifier exam today and become a PhD candidate. Congratulations, Emilie!!!

 

2026 January 5th, a new preprint from our lab: "Machine learning-based identification of blood biomarkers that distinguish precachectic and cachectic patients with pancreatic ductal adenocarcinoma" by Kayode Olumoyin in collaboration with Jenny Permuth lab and Kasia Rejniak, has been published in MedRxiv, link to the article